News Mile High Labs Raises $65MM to Purchase Mountains of Hemp May 1, 2019Add Commentby Shared Content
News InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program April 30, 2019Add Commentby Shared Content